financetom
Business
financetom
/
Business
/
Celsius founder Alex Mashinsky agrees to plead guilty to two fraud counts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Celsius founder Alex Mashinsky agrees to plead guilty to two fraud counts
Dec 3, 2024 12:50 PM

NEW YORK (Reuters) -Alex Mashinsky, the founder and former CEO of cryptocurrency lender Celsius Network, said on Tuesday he intends to plead guilty to two counts of fraud.

Mashinsky, 59, was indicted on July 13, 2023, on seven counts of fraud, conspiracy and market manipulation charges. Federal prosecutors in Manhattan said he misled customers of Celsius to persuade them to invest, and artificially inflated the value of his company's proprietary crypto token. He pleaded not guilty later that day.

U.S. District Judge John Koeltl in November denied a motion by Mashinsky to dismiss two criminal counts ahead of his trial, which had been slated for Jan. 28.

On Tuesday, during a hearing before Koeltl, Mashinsky said he agreed to plead guilty to two out of the seven counts he was initially charged with: commodities fraud, and a fraudulent scheme to manipulate the price of CEL, Celsius' in-house token.

Mashinsky was one of several crypto moguls to be charged with fraud after a slump in crypto prices in 2022 caused a number of companies, including now-bankrupt exchange FTX, to collapse.

Prices for digital assets like Bitcoin have since surged, in part due to optimism about U.S. President-elect Donald Trump's expected policies friendly toward cryptocurrency.

Founded in 2017, Celsius filed for Chapter 11 bankruptcy protection in July 2022 after customers rushed to withdraw deposits as crypto prices fell. Many were initially unable to access their funds. The company exited bankruptcy on Jan. 31, and has pivoted to Bitcoin mining.

Crypto lenders such as Celsius grew rapidly as crypto prices surged during the COVID pandemic. They promised easy loan access and eye-popping interest rates to depositors, then lent out tokens to institutional investors, hoping to profit from the difference.

Celsius was among the first in a series of bankruptcies in the cryptocurrency sector in 2022 as token prices cratered amid rising interest rates and stubbornly high inflation. It filed for bankruptcy shortly after Singapore-based crypto hedge fund Three Arrows Capital and rival crypto lender Voyager Digital did so.

Federal prosecutors in Manhattan accused Mashinsky and Celsius' former chief revenue officer, Roni Cohen-Pavon, with manipulating the market for the company's crypto token, known as Cel. Cohen-Pavon pleaded guilty in September 2023 and agreed to cooperate with prosecutors' investigation.

Prosecutors have said Mashinsky also personally reaped approximately $42 million in proceeds from selling his holdings of the Cel token.

FTX's founder Sam Bankman-Fried was convicted of stealing roughly $8 billion from the exchange's customers in November 2023 and sentenced in March to 25 years in prison.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jun 6, 2024
08:44 AM EDT, 06/06/2024 (MT Newswires) -- Consumer stocks were leaning lower pre-bell Thursday as the Consumer Staples Select Sector SPDR Fund (XLP) was down 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was marginally declining recently. Five Below ( FIVE ) declined by over 18% as its fiscal Q1 sales and earnings lagged market expectations and the...
GSK Buys Elsie Biotechnologies for $50 Million
GSK Buys Elsie Biotechnologies for $50 Million
Jun 6, 2024
08:41 AM EDT, 06/06/2024 (MT Newswires) -- GSK (GSK) said Thursday it has completed its acquisition Elsie Biotechnologies for up to $50 million. The acquisition will enhance GSK's research and development capabilities with Elsie's portfolio in oligonucleotide therapeutics, an alternative to traditional biologics. Price: 42.05, Change: +0.08, Percent Change: +0.19 ...
Bitdeer Technologies Group Agrees to Acquire Desiweminer in All-Stock Deal
Bitdeer Technologies Group Agrees to Acquire Desiweminer in All-Stock Deal
Jun 6, 2024
08:43 AM EDT, 06/06/2024 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) said Thursday that it has agreed to acquire all issued and outstanding shares of Desiweminer for 20 million Class A ordinary shares. Bitdeer ( BTDR ) said a portion of the shares to be issued will vest in equal installments over five or seven years. Additionally, Bitdeer...
Core Scientific Rejects CoreWeave's Acquisition Offer
Core Scientific Rejects CoreWeave's Acquisition Offer
Jun 6, 2024
08:44 AM EDT, 06/06/2024 (MT Newswires) -- Core Scientific ( CORZ ) said on Thursday it had rejected CoreWeave's proposal to buy all of its outstanding shares for $5.75 per share in cash, as it significantly undervalues the company and is not in the best interests of the shareholders. The company said it received the unsolicited proposal from CoreWeave on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved